Related Experiment Video
Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Power Considerations in Designing and Interpreting Adaptive Clinical Trials
Rui Wang1,2, Cyrus Mehta2,3
1Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston.
Adaptive clinical trials enable real-time study modifications. The Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS) trial evaluated apixaban versus aspirin in patients with cardioembolism risk factors.
Area of Science:
- Clinical Trials
- Cardiovascular Research
- Neurology
Background:
- Adaptive clinical trials offer flexibility in study design by allowing pre-planned modifications based on interim data.
- These modifications can optimize trial efficiency and validity, including sample size adjustments and treatment alterations.
- The Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS) trial investigated apixaban against aspirin in patients with cardioembolism risk factors.
Discussion:
- The ATTICUS trial's adaptive design allowed for data-driven adjustments, potentially enhancing the precision and relevance of the findings.
- Evaluating novel anticoagulants like apixaban is crucial for managing stroke risk in patients with cardioembolic sources.
- Comparing apixaban with aspirin provides insights into optimal secondary stroke prevention strategies.
Key Insights:
- The study reports on the comparative efficacy and safety of apixaban versus aspirin in a specific stroke population.
- Results from the ATTICUS trial contribute to the evidence base for antithrombotic therapy in stroke of undetermined source.
- Findings may inform clinical guidelines regarding the use of direct oral anticoagulants in secondary stroke prevention.
Outlook:
- Future research may explore long-term outcomes and cost-effectiveness of apixaban in this patient group.
- The application of adaptive trial methodologies in cardiovascular research is expected to grow.
- Continued investigation into personalized antithrombotic strategies based on individual patient risk profiles is warranted.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Preclinical Development: Overview
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.